Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Blood|March 24, 2018
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trialJorge E Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, et al.American Journal of Hematology|August 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO studyGiovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, et al.Haematologica|May 26, 2022
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trialStéphanie Dulucq, Franck E Nicolini, Delphine Rea, et al.The Lancet. Haematology|May 2, 2026
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trialFranck E Nicolini, Gabriel Etienne, Françoise Huguet, et al.The New England Journal of Medicine|November 5, 2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasJ E Cortes, D-W Kim, J Pinilla-Ibarz, et al.Leukemia|March 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Elza Lomaia, Christian Fabisch, et al.American Journal of Hematology|July 29, 2020
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patientsJulien Rohmer, Amélie Couteau-Chardon, Julie Trichereau, et al.American Journal of Hematology|April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO studyMatthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.Leukemia|February 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phaseMichael Lauseker, Tomasz Sacha, Hana Klamova, et al.Leukemia|July 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemiaJane F Apperley, Dragana Milojkovic, Nicholas C P Cross, et al.Pageof 12